Cargando…

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality

BACKGROUND: The risk of adverse cardiovascular events and mortality associated with testosterone replacement therapy is controversial. The purpose of this report was to evaluate the effect of testosterone replacement therapy (TRT) in men with secondary hypogonadism on the risk of myocardial infarcti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pantalone, Kevin M., George, Joyce, Ji, Xinge, Kattan, Michael W., Milinovich, Alex, Bauman, Janine M., Burguera, Bartolome, Zimmerman, Robert S., Misra-Hebert, Anita D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440106/ https://www.ncbi.nlm.nih.gov/pubmed/30976419 http://dx.doi.org/10.1186/s12610-019-0085-7

Ejemplares similares

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease
por: Pantalone, Kevin M., et al.
Publicado: (2018)

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model
por: Pantalone, Kevin M., et al.
Publicado: (2020)

Association between shared medical appointments and weight loss outcomes and anti‐obesity medication use in patients with obesity
por: Shibuya, Kelly, et al.
Publicado: (2020)

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system
por: Pantalone, Kevin M, et al.
Publicado: (2017)

Associations of weight loss with obesity‐related comorbidities in a large integrated health system
por: Mariam, Arshiya, et al.
Publicado: (2021)

Natural Language Processing Improves Detection of Nonsevere Hypoglycemia in Medical Records Versus Coding Alone in Patients With Type 2 Diabetes but Does Not Improve Prediction of Severe Hypoglycemia Events: An Analysis Using the Electronic Medical Record in a Large Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2020)

Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool
por: Pantalone, Kevin M., et al.
Publicado: (2023)

Is Testosterone Replacement Safe in Men with Cardiovascular Disease?
por: Ahmed, Talha, et al.
Publicado: (2020)

COVID-19 Home Monitoring After Diagnosis and Health Care Utilization in an Integrated Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2021)

Implementation Experience with a 30-Day Hospital Readmission Risk Score in a Large, Integrated Health System: A Retrospective Study
por: Misra-Hebert, Anita D., et al.
Publicado: (2022)

Trials of testosterone replacement reporting cardiovascular adverse events
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018)

Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system
por: Pantalone, Kevin M, et al.
Publicado: (2015)

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care
por: Misra-Hebert, Anita D., et al.
Publicado: (2018)

Changes in Characteristics and Treatment Patterns of Patients with Newly Diagnosed Type 2 Diabetes in a Large United States Integrated Health System between 2008 and 2013
por: Pantalone, Kevin M., et al.
Publicado: (2016)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

Impact of the COVID-19 Pandemic on Healthcare Workers’ Risk of Infection and Outcomes in a Large, Integrated Health System
por: Misra-Hebert, Anita D., et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on healthcare workers risk of infection and outcomes in a large, integrated health system.
por: Misra-Hebert, Anita D, et al.
Publicado: (2020)

Testosterone Replacement and Cardiovascular Safety: No Straight and Narrow!
por: Hans, Sartaj S, et al.
Publicado: (2015)

Testosterone deficiency and cardiovascular mortality
por: Morgentaler, Abraham
Publicado: (2015)

Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229
por: Pantalone, Kevin M., et al.
Publicado: (2011)

Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona G, Giovanni, et al.
Publicado: (2015)

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19
por: Jehi, Lara, et al.
Publicado: (2020)

Alternatives to testosterone replacement: testosterone restoration
por: McCullough, Andrew
Publicado: (2015)

Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing: Results From 11,672 Patients
por: Jehi, Lara, et al.
Publicado: (2020)

Corrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review
por: Corona, Giovanni, et al.
Publicado: (2016)

Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter
por: Misra-Hebert, Anita D., et al.
Publicado: (2016)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Testosterone replacement therapy
por: Shoskes, Daniel A., et al.
Publicado: (2016)

Testosterone Replacement Therapy
por: Hellstrom, Wayne J.G.
Publicado: (2004)

Use of Visual Decision Aids in Physician–Patient Communication: A Pilot Investigation
por: Mercer, Mary Beth, et al.
Publicado: (2017)

Primary Care Health Care Use for Patients With Type 2 Diabetes During the COVID-19 Pandemic
por: Misra-Hebert, Anita D., et al.
Publicado: (2021)

Is Oral Testosterone the New Frontier of Testosterone Replacement Therapy?
por: Ahmad, Syed W, et al.
Publicado: (2022)

Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
por: Hudson, Jemma, et al.
Publicado: (2022)

PSUN92 Type 1 Diabetes and Obesity: The Overlooked Epidemic
por: Burguera-Couce, Ella, et al.
Publicado: (2022)

Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men
por: Vincenzo, De Sanctis, et al.
Publicado: (2019)

An Algorithm for Classifying Patients Most Likely to Develop Severe Coronavirus Disease 2019 Illness
por: Kattan, Michael W., et al.
Publicado: (2020)

Transdermal testosterone replacement therapy in men
por: Ullah, M Iftekhar, et al.
Publicado: (2014)

The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis
por: Pantalone, Kevin M., et al.
Publicado: (2010)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_psad5t90f0bfkpo4a3q8c8p5of